Impact of access to treatment on patient‐reported outcomes among rheumatoid arthritis patients with tDMARDs and bDMARDS in two Latin‐American countries: A prospective observational study

Impact of access to treatment on patient‐reported outcomes among rheumatoid arthritis patients with tDMARDs and bDMARDS in two Latin‐American countries: A prospective observational study

Abstract Background and Aims A noninterventional prospective study was performed in Colombia and Peru. The aim was to describe the impact of access to treatment on Patient‐reported outcomes (PRO) in patients with Rheumatoid arthritis (RA) after failure to conventional disease‐modifying antirheumatic...

Full description

Bibliographic Details
Main Authors: Juan M. Reyes, Magda V. Gutierrez‐Ardila, Hugo Madariaga, William Otero, Renato Guzman, Jorge Izquierdo, David J. Del Castillo, Mauricio Abello, Patricia Velez, Dario Ponce de Leon, Tatjana Lukic, Luisa F. Amador, Natalia Castaño
Format: Article
Language:English
Published: Wiley 2023-03-01
Series:Health Science Reports
Subjects:
bDMARDs (biologic)
disease activity
healthcare access
Latin American
rheumatoid arthritis
tofacitinib
Online Access:https://doi.org/10.1002/hsr2.1034

Internet

https://doi.org/10.1002/hsr2.1034

Similar Items